Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / UNIT 10/15/2029
Symbol
DMAAU on Nasdaq
Price per share
$10.51
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
563,050
Total reported value
$5,765,445
% of total 13F portfolios
0%
Share change
-97,154
Value change
-$1,009,672
Number of holders
5
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 5 institutional investors reported holding 563,050 shares of Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU).

Institutional Holders of Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 563,050 $5,765,445 -$1,009,672 $10.51 5
2025 Q3 660,204 $6,731,720 -$3,517,895 $10.40 8
2025 Q2 986,129 $10,176,850 -$23,363,644 $10.32 9
2025 Q1 3,289,223 $33,388,110 +$33,388,110 $10.17 15